menu toggle

Medical education

Female doc at computer_GettyImages-1224302214_RGB_flipped

New drug approvals

Abemaciclib oral (Verzenio®)

Mirvetuximab soravtansine-gynx (Elahere™)

Sacituzumab govitecan-hziy injection (Trodelvy®)

Elacestrant tablets (Orserdu™)

Cemiplimab-rwlc injection (Libtayo®)

Tremelimumab-actl injection (Imjudo®)

Teclistamab-cqyv injection (Tecvayli™)

Articles

Artificial intelligence model analyzes pathology slides to predict colorectal cancer recurrence

Colorectal cancers (CRCs) can vary considerably from patient to patient, making histologic interpretation complex. To aid in interpreting H&E slides, researchers have developed QuantCRC, a quantitative segmentation algorithm that assesses known histologic features in digitized CRC images. This analysis can provide useful information to help guide therapy and surveillance in CRC.